| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.28 | 4e-07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |